Last 12 months
Inside the activity.
0 purchase rows · 48 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 4 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 5 |
| Mar 2026 | 0 | 12 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 6 |
| Jun 2026 | 0 | 4 |
| Jul 2026 | 0 | 3 |
| Aug 2026 | 0 | 4 |
| Sep 2026 | 0 | 4 |
| Oct 2026 | 0 | 1 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 21, 2023 Filed Aug 24, 2023 00:44 UTC |
Leonard Matthew JDirector
|
GrantCommon Stock | 7,583 | $0.00 | $0.00 |
DisclosureSEC source: 0001773152-23-000005 · wk-form4_1692837837.xml · nonDerivative · entry 1 Leonard Matthew J · CIK 0001773152 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,583 F1 · balance_after: Represents a restricted stock award that will vest in three equal annual installments on the first, second and third anniversaries of the date of grant. Read SEC document |
| August 16, 2023 Filed Aug 17, 2023 00:00 UTC |
MERIDIAN VENTURE PARTNERS II LP10% owner
Meridian Venture Partners II, Co.10% owner
Brown Robert E. JR10% owner
|
SaleCommon Stock | 200,000 | $58.50 | $11,700,000.00 |
DisclosureSEC source: 0001104659-23-092750 · tm2324006-1_4seq1.xml · nonDerivative · entry 1 MERIDIAN VENTURE PARTNERS II LP · CIK 0001109507 · 10% owner Meridian Venture Partners II GP, L.P. · CIK 0001580170 · 10% owner Meridian Venture Partners II, Co. · CIK 0001580169 · 10% owner Brown Robert E. JR · CIK 0001579672 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,819,259 Read SEC document |
| August 15, 2023 Filed Aug 16, 2023 00:39 UTC |
Lalwani NikhilDirector · PRESIDENT & CEO
|
Exercise / conversionStock Option (right to buy) · Derivative | 11,616 | $29.00 Strike: $29.00 | $336,864.00 |
DisclosureSEC source: 0001822629-23-000002 · wk-form4_1692146335.xml · derivative · entry 4 Lalwani Nikhil · CIK 0001822629 · Director · PRESIDENT & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 168,027 Underlying: Common Stock · 11,616 shares Expires 2030-09-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 25% of the total options vested on each of September 8, 2021 and September 8, 2022. 25% of the total options will vest on each of September 8, 2023 and September 8, 2024. Read SEC document |
| August 15, 2023 Filed Aug 16, 2023 00:39 UTC |
Lalwani NikhilDirector · PRESIDENT & CEO
|
SaleCommon Stock | 11,616 | $61.13 | $710,086.08 |
DisclosureSEC source: 0001822629-23-000002 · wk-form4_1692146335.xml · nonDerivative · entry 3 Lalwani Nikhil · CIK 0001822629 · Director · PRESIDENT & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 353,390 F1 · price: Reflects the weighted average price of sales on August 15, 2023. The shares were sold in multiple transactions at prices ranging from $60.68 to $61.87, inclusive. Read SEC document |
| August 15, 2023 Filed Aug 16, 2023 00:39 UTC |
Lalwani NikhilDirector · PRESIDENT & CEO
|
Exercise / conversionCommon Stock | 11,616 | $29.00 | $336,864.00 |
DisclosureSEC source: 0001822629-23-000002 · wk-form4_1692146335.xml · nonDerivative · entry 2 Lalwani Nikhil · CIK 0001822629 · Director · PRESIDENT & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 365,006 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 15, 2023 Filed Aug 16, 2023 23:07 UTC |
Shanmugam MuthusamyDirector · HEAD OF R&D, COO-NOVITIUM OPS
|
SaleCommon Stock | 22,110 | $61.60 | $1,361,976.00 |
DisclosureSEC source: 0001870913-23-000003 · wk-form4_1692227210.xml · nonDerivative · entry 3 Shanmugam Muthusamy · CIK 0001870913 · Director · HEAD OF R&D, COO-NOVITIUM OPS 10b5-1 filing: Plan reported Ownership: Indirect · Held by Esjay LLC Disclosed balance after: 1,182,620 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 21, 2023. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $60.81 to $62.59, inclusive. F3 · ownership.nature: The reporting person holds voting and dispositive power over the shares held by Esjay LLC. Read SEC document |
| August 14, 2023 Filed Aug 16, 2023 00:45 UTC |
Pera Antonio RDirector
|
SaleCommon Stock | 3,000 | $60.37 | $181,110.00 |
DisclosureSEC source: 0001689325-23-000002 · wk-form4_1692146735.xml · nonDerivative · entry 1 Pera Antonio R · CIK 0001689325 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 33,627 F1 · price: Reflects the weighted average price of sales on August 14, 2023. The shares were sold in multiple transactions at prices ranging from $60.12 to $60.83, inclusive. Read SEC document |
| August 14, 2023 Filed Aug 16, 2023 23:07 UTC |
Shanmugam MuthusamyDirector · HEAD OF R&D, COO-NOVITIUM OPS
|
SaleCommon Stock | 27,890 | $61.15 | $1,705,473.50 |
DisclosureSEC source: 0001870913-23-000003 · wk-form4_1692227210.xml · nonDerivative · entry 2 Shanmugam Muthusamy · CIK 0001870913 · Director · HEAD OF R&D, COO-NOVITIUM OPS 10b5-1 filing: Plan reported Ownership: Indirect · Held by Esjay LLC Disclosed balance after: 1,204,730 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 21, 2023. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $60.12 to $62.58, inclusive. F3 · ownership.nature: The reporting person holds voting and dispositive power over the shares held by Esjay LLC. Read SEC document |
| August 14, 2023 Filed Aug 16, 2023 20:24 UTC |
CAREY STEPHEN P.SVP & CFO
|
SaleCommon Stock | 17,639 | $61.37 | $1,082,505.43 |
DisclosureSEC source: 0001674236-23-000004 · wk-form4_1692217456.xml · nonDerivative · entry 1 CAREY STEPHEN P. · CIK 0001674236 · SVP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 155,839 F1 · price: Reflects the weighted average price of sales on August 14, 2023. The shares were sold in multiple transactions at prices ranging from $60.50 to $61.86, inclusive. Read SEC document |
| August 11, 2023 Filed Aug 16, 2023 00:39 UTC |
Lalwani NikhilDirector · PRESIDENT & CEO
|
SaleCommon Stock | 56,666 | $57.75 | $3,272,461.50 |
DisclosureSEC source: 0001822629-23-000002 · wk-form4_1692146335.xml · nonDerivative · entry 1 Lalwani Nikhil · CIK 0001822629 · Director · PRESIDENT & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 353,390 Read SEC document |
| August 01, 2023 Filed Aug 3, 2023 22:03 UTC |
Gassert ChadSVP - CORP. DEV. & STRATEGY
|
SaleCommon Stock | 20,000 | $51.06 | $1,021,200.00 |
DisclosureSEC source: 0001871002-23-000004 · wk-form4_1691100197.xml · nonDerivative · entry 2 Gassert Chad · CIK 0001871002 · SVP - CORP. DEV. & STRATEGY 10b5-1 filing: Plan reported Ownership: Indirect · Held by Chali Properties LLC Disclosed balance after: 333,226 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 21, 2023. F2 · price: Reflects the weighted average price of sales on August 1, 2023. The shares were sold in multiple transactions at prices ranging from $50.52 to $52.33, inclusive. F3 · ownership.nature: The reporting person holds voting and dispositive power over the shares held by Chali Properties LLC. Read SEC document |
| July 21, 2023 Filed Jul 21, 2023 23:15 UTC |
Shanmugam MuthusamyDirector · HEAD OF R&D, COO-NOVITIUM OPS
|
SaleCommon Stock | 11,500 | $52.56 | $604,440.00 |
DisclosureSEC source: 0001104659-23-083131 · tm2321830-1_4seq1.xml · nonDerivative · entry 4 Shanmugam Muthusamy · CIK 0001870913 · Director · HEAD OF R&D, COO-NOVITIUM OPS 10b5-1 filing: Plan reported Ownership: Indirect · Held by Esjay LLC Disclosed balance after: 1,232,620 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 21, 2023. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $52.10 to $53.32, inclusive. F3 · ownership.nature: The reporting person holds voting and dispositive power over the shares held by Esjay LLC. Read SEC document |
| July 20, 2023 Filed Jul 21, 2023 23:15 UTC |
Shanmugam MuthusamyDirector · HEAD OF R&D, COO-NOVITIUM OPS
|
SaleCommon Stock | 6,000 | $51.52 | $309,120.00 |
DisclosureSEC source: 0001104659-23-083131 · tm2321830-1_4seq1.xml · nonDerivative · entry 3 Shanmugam Muthusamy · CIK 0001870913 · Director · HEAD OF R&D, COO-NOVITIUM OPS 10b5-1 filing: Plan reported Ownership: Indirect · Held by Esjay LLC Disclosed balance after: 1,244,120 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 21, 2023. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $51.00 to $52.08, inclusive. F3 · ownership.nature: The reporting person holds voting and dispositive power over the shares held by Esjay LLC. Read SEC document |
| July 19, 2023 Filed Jul 21, 2023 23:15 UTC |
Shanmugam MuthusamyDirector · HEAD OF R&D, COO-NOVITIUM OPS
|
SaleCommon Stock | 5,969 | $51.48 | $307,284.12 |
DisclosureSEC source: 0001104659-23-083131 · tm2321830-1_4seq1.xml · nonDerivative · entry 2 Shanmugam Muthusamy · CIK 0001870913 · Director · HEAD OF R&D, COO-NOVITIUM OPS 10b5-1 filing: Plan reported Ownership: Indirect · Held by Esjay LLC Disclosed balance after: 1,250,120 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 21, 2023. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $50.95 to $52.28, inclusive. The reporting person undertakes to provide to ANI Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2, 4 and 5 to this Form 4. F3 · ownership.nature: The reporting person holds voting and dispositive power over the shares held by Esjay LLC. Read SEC document |
| July 18, 2023 Filed Jul 19, 2023 00:06 UTC |
Shanmugam MuthusamyDirector · HEAD OF R&D, COO-NOVITIUM OPS
|
SaleCommon Stock | 6,700 | $51.84 | $347,328.00 |
DisclosureSEC source: 0001104659-23-082112 · tm2321566-1_4seq1.xml · nonDerivative · entry 4 Shanmugam Muthusamy · CIK 0001870913 · Director · HEAD OF R&D, COO-NOVITIUM OPS 10b5-1 filing: Plan reported Ownership: Indirect · Held by Esjay LLC Disclosed balance after: 1,256,089 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 21, 2023. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $51.62 to $52.38, inclusive. F3 · ownership.nature: The reporting person holds voting and dispositive power over the shares held by Esjay LLC. Read SEC document |
| July 18, 2023 Filed Jul 19, 2023 23:14 UTC |
Cook MeredithSR. VP, GENERAL COUNSEL & SEC.
|
Tax withholdingCommon Stock | 1,743 | $51.89 | $90,444.27 |
DisclosureSEC source: 0001938861-23-000003 · wk-form4_1689808444.xml · nonDerivative · entry 1 Cook Meredith · CIK 0001938861 · SR. VP, GENERAL COUNSEL & SEC. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,799 F1 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 4,820 shares of restricted stock, the grant of which was previously reported. Read SEC document |
| July 17, 2023 Filed Jul 19, 2023 00:06 UTC |
Shanmugam MuthusamyDirector · HEAD OF R&D, COO-NOVITIUM OPS
|
SaleCommon Stock | 9,831 | $51.06 | $501,970.86 |
DisclosureSEC source: 0001104659-23-082112 · tm2321566-1_4seq1.xml · nonDerivative · entry 3 Shanmugam Muthusamy · CIK 0001870913 · Director · HEAD OF R&D, COO-NOVITIUM OPS 10b5-1 filing: Plan reported Ownership: Indirect · Held by Esjay LLC Disclosed balance after: 1,262,789 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 21, 2023. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $49.77 to $51.66, inclusive. F3 · ownership.nature: The reporting person holds voting and dispositive power over the shares held by Esjay LLC. Read SEC document |
| July 14, 2023 Filed Jul 19, 2023 00:06 UTC |
Shanmugam MuthusamyDirector · HEAD OF R&D, COO-NOVITIUM OPS
|
SaleCommon Stock | 10,000 | $50.43 | $504,300.00 |
DisclosureSEC source: 0001104659-23-082112 · tm2321566-1_4seq1.xml · nonDerivative · entry 2 Shanmugam Muthusamy · CIK 0001870913 · Director · HEAD OF R&D, COO-NOVITIUM OPS 10b5-1 filing: Plan reported Ownership: Indirect · Held by Esjay LLC Disclosed balance after: 1,272,620 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 21, 2023. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $49.98 to $50.83, inclusive. The reporting person undertakes to provide to ANI Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2,4 and 5 to this Form 4. F3 · ownership.nature: The reporting person holds voting and dispositive power over the shares held by Esjay LLC. Read SEC document |
| July 03, 2023 Filed Jul 6, 2023 20:15 UTC |
Gassert ChadSVP - CORP. DEV. & STRATEGY
|
SaleCommon Stock | 20,000 | $53.43 | $1,068,600.00 |
DisclosureSEC source: 0001104659-23-078742 · tm2320740-1_4seq1.xml · nonDerivative · entry 2 Gassert Chad · CIK 0001871002 · SVP - CORP. DEV. & STRATEGY 10b5-1 filing: Plan reported Ownership: Indirect · Held by Chali Properties LLC Disclosed balance after: 353,226 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 21, 2023. F2 · price: Reflects the weighted average price of sales on July 3, 2023. The shares were sold in multiple transactions at prices ranging from $52.76 to $54.10, inclusive. F3 · ownership.nature: The reporting person holds voting and dispositive power over the shares held by Chali Properties LLC. Read SEC document |
| June 23, 2023 Filed Jun 24, 2023 00:01 UTC Amendment |
Shanmugam MuthusamyDirector · HEAD OF R&D, COO-NOVITIUM OPS
|
SaleCommon Stock | 10,000 | $51.49 | $514,900.00 |
DisclosureSEC source: 0001104659-23-074399 · tm2319615-2_4aseq1.xml · nonDerivative · entry 5 Shanmugam Muthusamy · CIK 0001870913 · Director · HEAD OF R&D, COO-NOVITIUM OPS 10b5-1 filing: Plan reported Ownership: Indirect · Held by Esjay LLC Disclosed balance after: 1,282,620 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 21, 2023. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $50.99 to $52.08, inclusive. F3 · ownership.nature: The reporting person holds voting and dispositive power over the shares held by Esjay LLC. Read SEC document |
| June 22, 2023 Filed Jun 23, 2023 00:00 UTC |
Shanmugam MuthusamyDirector · HEAD OF R&D, COO-NOVITIUM OPS
|
SaleCommon Stock | 13,500 | $51.38 | $693,630.00 |
DisclosureSEC source: 0001104659-23-073894 · tm2319370-1_4seq1.xml · nonDerivative · entry 3 Shanmugam Muthusamy · CIK 0001870913 · Director · HEAD OF R&D, COO-NOVITIUM OPS 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 7,407 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 21, 2023. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $50.85 to $51.84, inclusive. Read SEC document |
| June 22, 2023 Filed Jun 24, 2023 00:01 UTC Amendment |
Shanmugam MuthusamyDirector · HEAD OF R&D, COO-NOVITIUM OPS
|
SaleCommon Stock | 13,500 | $51.38 | $693,630.00 |
DisclosureSEC source: 0001104659-23-074399 · tm2319615-2_4aseq1.xml · nonDerivative · entry 4 Shanmugam Muthusamy · CIK 0001870913 · Director · HEAD OF R&D, COO-NOVITIUM OPS 10b5-1 filing: Plan reported Ownership: Indirect · Held by Esjay LLC Disclosed balance after: 1,292,620 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 21, 2023. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $50.85 to $51.84, inclusive. F3 · ownership.nature: The reporting person holds voting and dispositive power over the shares held by Esjay LLC. Read SEC document |
| June 22, 2023 Filed Jun 24, 2023 00:00 UTC |
Gassert ChadSVP - CORP. DEV. & STRATEGY
|
SaleCommon Stock | 20,000 | $51.32 | $1,026,400.00 |
DisclosureSEC source: 0001104659-23-074398 · tm2319615-1_4seq1.xml · nonDerivative · entry 2 Gassert Chad · CIK 0001871002 · SVP - CORP. DEV. & STRATEGY 10b5-1 filing: Plan reported Ownership: Indirect · Held by Chali Properties LLC Disclosed balance after: 373,226 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 21, 2023. F2 · ownership.nature: The reporting person holds voting and dispositive power over the shares held by Chali Properties LLC. Read SEC document |
| June 21, 2023 Filed Jun 23, 2023 00:00 UTC |
Shanmugam MuthusamyDirector · HEAD OF R&D, COO-NOVITIUM OPS
|
SaleCommon Stock | 11,843 | $51.95 | $615,243.85 |
DisclosureSEC source: 0001104659-23-073894 · tm2319370-1_4seq1.xml · nonDerivative · entry 2 Shanmugam Muthusamy · CIK 0001870913 · Director · HEAD OF R&D, COO-NOVITIUM OPS 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 20,907 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 21, 2023. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $51.13 to $52.56, inclusive. Read SEC document |
| June 21, 2023 Filed Jun 24, 2023 00:01 UTC Amendment |
Shanmugam MuthusamyDirector · HEAD OF R&D, COO-NOVITIUM OPS
|
SaleCommon Stock | 11,843 | $51.95 | $615,243.85 |
DisclosureSEC source: 0001104659-23-074399 · tm2319615-2_4aseq1.xml · nonDerivative · entry 3 Shanmugam Muthusamy · CIK 0001870913 · Director · HEAD OF R&D, COO-NOVITIUM OPS 10b5-1 filing: Plan reported Ownership: Indirect · Held by Esjay LLC Disclosed balance after: 1,306,120 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 21, 2023. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $51.13 to $52.56, inclusive. F3 · ownership.nature: The reporting person holds voting and dispositive power over the shares held by Esjay LLC. Read SEC document |
| June 20, 2023 Filed Jun 23, 2023 00:00 UTC |
Shanmugam MuthusamyDirector · HEAD OF R&D, COO-NOVITIUM OPS
|
SaleCommon Stock | 14,657 | $51.93 | $761,138.01 |
DisclosureSEC source: 0001104659-23-073894 · tm2319370-1_4seq1.xml · nonDerivative · entry 1 Shanmugam Muthusamy · CIK 0001870913 · Director · HEAD OF R&D, COO-NOVITIUM OPS 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 32,750 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 21, 2023. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $50.63 to $52.80, inclusive. The reporting person undertakes to provide to ANI Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2, 3 and 4 to this Form 4. Read SEC document |
| June 20, 2023 Filed Jun 24, 2023 00:01 UTC Amendment |
Shanmugam MuthusamyDirector · HEAD OF R&D, COO-NOVITIUM OPS
|
SaleCommon Stock | 14,657 | $51.93 | $761,138.01 |
DisclosureSEC source: 0001104659-23-074399 · tm2319615-2_4aseq1.xml · nonDerivative · entry 2 Shanmugam Muthusamy · CIK 0001870913 · Director · HEAD OF R&D, COO-NOVITIUM OPS 10b5-1 filing: Plan reported Ownership: Indirect · Held by Esjay LLC Disclosed balance after: 1,317,963 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 21, 2023. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $50.63 to $52.80, inclusive. The reporting person undertakes to provide to ANIPharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2, 4, 5 and 6 to this Form 4. F3 · ownership.nature: The reporting person holds voting and dispositive power over the shares held by Esjay LLC. Read SEC document |
| May 23, 2023 Filed May 24, 2023 20:36 UTC |
TANNENBAUM RENEE PDirector
|
GrantCommon Stock | 6,865 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-064160 · tm2316872-6_4seq1.xml · nonDerivative · entry 1 TANNENBAUM RENEE P · CIK 0001543174 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,211 F1 · kind: Represents a restricted stock award that will vest in full on May 23, 2024. Read SEC document |
| May 23, 2023 Filed May 24, 2023 20:34 UTC |
Walsh Patrick DDirector
|
GrantCommon Stock | 6,865 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-064158 · tm2316872-5_4seq1.xml · nonDerivative · entry 1 Walsh Patrick D · CIK 0001720568 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,302 F1 · kind: Represents a restricted stock award that will vest in full on May 23, 2024. Read SEC document |
| May 23, 2023 Filed May 24, 2023 20:33 UTC |
Thoma JeanneDirector
|
GrantCommon Stock | 6,865 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-064155 · tm2316872-4_4seq1.xml · nonDerivative · entry 1 Thoma Jeanne · CIK 0001819879 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,199 F1 · kind: Represents a restricted stock award that will vest in full on May 23, 2024. Read SEC document |
| May 23, 2023 Filed May 24, 2023 20:32 UTC |
Pera Antonio RDirector
|
GrantCommon Stock | 6,865 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-064152 · tm2316872-3_4seq1.xml · nonDerivative · entry 1 Pera Antonio R · CIK 0001689325 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,627 F1 · kind: Represents a restricted stock award that will vest in full on May 23, 2024. Read SEC document |
| May 23, 2023 Filed May 24, 2023 20:31 UTC |
NASH DAVIDDirector
|
GrantCommon Stock | 6,865 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-064146 · tm2316872-2_4seq1.xml · nonDerivative · entry 1 NASH DAVID · CIK 0001251968 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,561 F1 · kind: Represents a restricted stock award that will vest in full on May 23, 2024. Read SEC document |
| May 23, 2023 Filed May 24, 2023 20:30 UTC |
HAUGHEY THOMASDirector
|
GrantCommon Stock | 6,865 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-064140 · tm2316872-1_4seq1.xml · nonDerivative · entry 1 HAUGHEY THOMAS · CIK 0001272247 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,116 F1 · kind: Represents a restricted stock award that will vest in full on May 23, 2024. Read SEC document |
| April 10, 2023 Filed Apr 12, 2023 20:43 UTC |
CAREY STEPHEN P.SVP & CFO
|
Tax withholdingCommon Stock | 4,534 | $38.50 | $174,559.00 |
DisclosureSEC source: 0001104659-23-044638 · tm2312564-2_4seq1.xml · nonDerivative · entry 1 CAREY STEPHEN P. · CIK 0001674236 · SVP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 173,478 F1 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 9,942 shares of restricted stock, the grant of which was previously reported. Read SEC document |
| April 10, 2023 Filed Apr 12, 2023 20:42 UTC |
Marken James G.SVP OPS & PROD DEV
|
Tax withholdingCommon Stock | 2,289 | $38.50 | $88,126.50 |
DisclosureSEC source: 0001104659-23-044634 · tm2312564-1_4seq1.xml · nonDerivative · entry 1 Marken James G. · CIK 0001579587 · SVP OPS & PROD DEV 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 131,627 F1 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 6,137 shares of restricted stock, the grant of which was previously reported. Read SEC document |
| March 28, 2023 Filed Mar 31, 2023 00:01 UTC |
Marken James G.SVP OPS & PROD DEV
|
Tax withholdingCommon Stock | 524 | $38.62 | $20,236.88 |
DisclosureSEC source: 0001104659-23-039340 · tm2311020-2_4seq1.xml · nonDerivative · entry 1 Marken James G. · CIK 0001579587 · SVP OPS & PROD DEV 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 112,206 F1 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 1,712 shares of restricted stock, the grant of which was previously reported. Read SEC document |
| March 28, 2023 Filed Mar 31, 2023 00:00 UTC |
CAREY STEPHEN P.SVP AND CFO
|
Tax withholdingCommon Stock | 1,420 | $38.62 | $54,840.40 |
DisclosureSEC source: 0001104659-23-039338 · tm2311020-1_4seq1.xml · nonDerivative · entry 1 CAREY STEPHEN P. · CIK 0001674236 · SVP AND CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 137,486 F1 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 3,113 shares of restricted stock, the grant of which was previously reported. Read SEC document |
| March 23, 2023 Filed Mar 28, 2023 00:02 UTC |
Marken James G.SVP OPS & PROD DEV
|
Tax withholdingCommon Stock | 2,452 | $37.82 | $92,734.64 |
DisclosureSEC source: 0001104659-23-037251 · tm2310677-3_4seq1.xml · nonDerivative · entry 1 Marken James G. · CIK 0001579587 · SVP OPS & PROD DEV 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 112,730 F1 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 8,010 shares of restricted stock, the grant of which was previously reported. Read SEC document |
| March 23, 2023 Filed Mar 28, 2023 00:01 UTC |
Lalwani NikhilDirector · PRESIDENT & CEO
|
Tax withholdingCommon Stock | 17,455 | $37.82 | $660,148.10 |
DisclosureSEC source: 0001104659-23-037250 · tm2310677-2_4seq1.xml · nonDerivative · entry 1 Lalwani Nikhil · CIK 0001822629 · Director · PRESIDENT & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 250,840 F1 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 34,124 shares of restricted stock, the grant of which was previously reported. Read SEC document |
| March 23, 2023 Filed Mar 28, 2023 00:00 UTC |
CAREY STEPHEN P.SVP AND CFO
|
Tax withholdingCommon Stock | 4,224 | $37.82 | $159,751.68 |
DisclosureSEC source: 0001104659-23-037249 · tm2310677-1_4seq1.xml · nonDerivative · entry 1 CAREY STEPHEN P. · CIK 0001674236 · SVP AND CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 138,906 F1 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 13,617 shares of restricted stock, the grant of which was previously reported. Read SEC document |
| March 07, 2023 Filed Mar 9, 2023 23:48 UTC |
Mutz ChristopherHEAD OF RARE DISEASE
|
Tax withholdingCommon Stock | 476 | $44.23 | $21,053.48 |
DisclosureSEC source: 0001104659-23-030710 · tm239061-5_4seq1.xml · nonDerivative · entry 2 Mutz Christopher · CIK 0001846487 · HEAD OF RARE DISEASE 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,660 F2 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 1,619 shares of restricted stock, the grant of which was previously reported. Read SEC document |
| March 07, 2023 Filed Mar 9, 2023 23:48 UTC |
Mutz ChristopherHEAD OF RARE DISEASE
|
Tax withholdingCommon Stock | 1,426 | $44.23 | $63,071.98 |
DisclosureSEC source: 0001104659-23-030710 · tm239061-5_4seq1.xml · nonDerivative · entry 1 Mutz Christopher · CIK 0001846487 · HEAD OF RARE DISEASE 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,136 F1 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 4,857 shares of restricted stock, the grant of which was previously reported. Read SEC document |
| March 07, 2023 Filed Mar 9, 2023 23:46 UTC |
Gutwerg OriSVP, GENERICS
|
Tax withholdingCommon Stock | 586 | $44.23 | $25,918.78 |
DisclosureSEC source: 0001104659-23-030709 · tm239061-4_4seq1.xml · nonDerivative · entry 2 Gutwerg Ori · CIK 0001846478 · SVP, GENERICS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,027 F2 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 1,619 shares of restricted stock, the grant of which was previously reported. Read SEC document |
| March 07, 2023 Filed Mar 9, 2023 23:46 UTC |
Gutwerg OriSVP, GENERICS
|
Tax withholdingCommon Stock | 1,756 | $44.23 | $77,667.88 |
DisclosureSEC source: 0001104659-23-030709 · tm239061-4_4seq1.xml · nonDerivative · entry 1 Gutwerg Ori · CIK 0001846478 · SVP, GENERICS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,613 F1 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 4,857 shares of restricted stock, the grant of which was previously reported. Read SEC document |
| March 07, 2023 Filed Mar 9, 2023 23:45 UTC |
CAREY STEPHEN P.SVP AND CFO
|
Tax withholdingCommon Stock | 864 | $44.23 | $38,214.72 |
DisclosureSEC source: 0001104659-23-030708 · tm239061-3_4seq1.xml · nonDerivative · entry 2 CAREY STEPHEN P. · CIK 0001674236 · SVP AND CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 143,130 F2 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 2,822 shares of restricted stock, the grant of which was previously reported. Read SEC document |
| March 07, 2023 Filed Mar 9, 2023 23:45 UTC |
CAREY STEPHEN P.SVP AND CFO
|
Tax withholdingCommon Stock | 2,639 | $44.23 | $116,722.97 |
DisclosureSEC source: 0001104659-23-030708 · tm239061-3_4seq1.xml · nonDerivative · entry 1 CAREY STEPHEN P. · CIK 0001674236 · SVP AND CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 143,994 F1 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 8,468 shares of restricted stock, the grant of which was previously reported. Read SEC document |
| March 07, 2023 Filed Mar 9, 2023 23:44 UTC |
Lalwani NikhilDirector · PRESIDENT & CEO
|
Tax withholdingCommon Stock | 4,265 | $44.23 | $188,640.95 |
DisclosureSEC source: 0001104659-23-030706 · tm239061-2_4seq1.xml · nonDerivative · entry 2 Lalwani Nikhil · CIK 0001822629 · Director · PRESIDENT & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 268,295 F2 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 8,338 shares of restricted stock, the grant of which was previously reported. Read SEC document |
| March 07, 2023 Filed Mar 9, 2023 23:44 UTC |
Lalwani NikhilDirector · PRESIDENT & CEO
|
Tax withholdingCommon Stock | 9,397 | $44.23 | $415,629.31 |
DisclosureSEC source: 0001104659-23-030706 · tm239061-2_4seq1.xml · nonDerivative · entry 1 Lalwani Nikhil · CIK 0001822629 · Director · PRESIDENT & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 272,560 F1 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 25,013 shares of restricted stock, the grant of which was previously reported. Read SEC document |
| March 07, 2023 Filed Mar 9, 2023 21:36 UTC |
Marken James G.SVP OPS & PROD DEV
|
Tax withholdingCommon Stock | 509 | $44.23 | $22,513.07 |
DisclosureSEC source: 0001104659-23-030618 · tm239061-1_4seq1.xml · nonDerivative · entry 2 Marken James G. · CIK 0001579587 · SVP OPS & PROD DEV 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,182 Read SEC document |
| March 07, 2023 Filed Mar 9, 2023 21:36 UTC |
Marken James G.SVP OPS & PROD DEV
|
Tax withholdingCommon Stock | 1,951 | $44.23 | $86,292.73 |
DisclosureSEC source: 0001104659-23-030618 · tm239061-1_4seq1.xml · nonDerivative · entry 1 Marken James G. · CIK 0001579587 · SVP OPS & PROD DEV 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,691 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.